Article · Volume 20, Issue 3 · pp. 853–862

Therapeutic Alleviation and Mechanism of Glabridin Liposome on Histamine-induced Atopic Dermatitis

Yongjie Lu¹, Lushi Cheng¹, Lu Ren¹, Dongqiu Chen¹, Shumin Guan¹, Siyang Zhu¹, Xian Xu¹, Bing Zhang^1,2, Minghui Tang¹, Chijian Zhang¹, Yong Ai¹, Lanyue Zhang^1,2, Tinggang He¹

¹Hua An Tang Biotech Group Co., Ltd., Guangzhou, Guangdong, China.
²Guangdong He Ji Biotech Co., Ltd., Guangzhou, CHINA.
³Current Affiliation: School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, China.

Abstract

Background: One of the primary flavonoids found in the Glycyrrhiza glabra is called glabridin, which has anti-inflammatory, anti-bacterial, and antineoplastic effects. However, the insolubility of glabridin in water limits its application. Liposomes can increase the solubility of insoluble drugs and improve their bioavailability.Objectives: We examined the potential for the treatment of glabridin liposomes on histamine-induced atopic dermatitis.Materials and Methods: After GL treatment, histopathology, inflammatory cytokines, and atopic dermatitis-related proteins were used to evaluate the therapeutic effect of GL.Results: Glabridin liposomes alleviated histamine-induced scratching behavior; reduced mast cell proliferation, infiltration, and degranulation; and restrained the expression of associated pro-inflammatory cytokines. Additionally, glabridin liposomes restored nerve growth factor to normal levels and enhanced the expression of filaggrin to promote cuticle growth and repair skin damage caused by atopic dermatitis.Conclusion: Glabridin liposomes may relieve histamine-induced skin hypersensitivity and cortical hyperplasia by inhibiting the production of inflammatory cytokines, demonstrating their potential for the clinical treatment of atopic dermatitis.

Keywords: Glabridin liposome; anti-inflammation; atopic dermatitis

The full text of this article is available as a PDF. Open the PDF.